- Education
-
Research
Current research
Talent
-
Collaboration
Businesses
Government agencies and institutions
Alumni
-
About AU
Organisation
Job at AU
Mads Fuglsang Kjølby, affiliated Anders Nykjær's lab at DANDRITE/PROMEMO, and Ole Schmeltz Søgaard, will test the effect of Camostat Mesylate on SARS-CoV-2 infections in Covid-19 patients.
2020.03.26 | Susanne Schousboe Sjøgaard
Mads Fuglsang Kjølby. Photo: Tonny Foghmar, AUH
Associate professor and MD, PhD, Mads Fuglsang Kjølby from Department of Biomedicine, Aarhus University, and Department of Clinical Pharmacology, Aarhus University Hospital, and Associate professor and MD, PhD Ole Schmeltz Søgaard from Department of Clinical Medicine, Aarhus University, and Department of Infectious Diseases, Aarhus University Hospital, were interviewed about the upcoming clinical trial by TV2 (link to interview)
Read more about the researchers and the clinical trial here (health.au.dk).